Protocol summary

Study aim
To compare the effects of dexmedetomidine administration before versus after induction of anesthesia on intraoperative fentanyl and isoflurane consumption, hemodynamic responses, and postoperative recovery outcomes in patients undergoing laparoscopic cholecystectomy
Design
A randomized, double-blind, parallel-group, placebo-controlled clinical trial with a 1:1 allocation ratio.
Settings and conduct
This study will be conducted at Loghman Hakim Hospital, Tehran, Iran, in eligible patients undergoing elective laparoscopic cholecystectomy. After screening for eligibility and obtaining written informed consent, participants will be randomly assigned to two groups. Anesthetic interventions will be performed according to the study protocol, and intraoperative data and postoperative outcomes will be recorded and compared.
Participants/Inclusion and exclusion criteria
Adults aged 18–65 years, ASA I–II, undergoing elective laparoscopic cholecystectomy under general anesthesia. Exclusion criteria: dexmedetomidine allergy, significant bradycardia or conduction disorders, major cardiovascular disease, uncontrolled hypertension, severe hepatic impairment, regular opioid use, alpha-2 agonist use within 7 days, pregnancy, or breastfeeding
Intervention groups
Group A: Dexmedetomidine 1 µg/kg infused over 10 minutes before anesthesia induction, followed by 0.5 µg/kg/h maintenance infusion Group B: Placebo before induction, followed by dexmedetomidine at the same loading and maintenance doses after induction
Main outcome variables
Total intraoperative fentanyl consumption (µg/ kg) Total intraoperative isoflurane consumption (mL)

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20210415050983N16
Registration date: 2026-11-19, 1405/08/28
Registration timing: prospective

Last update: 2026-11-19, 1405/08/28
Update count: 0
Registration date
2026-11-19, 1405/08/28
Registrant information
Name
Sogol Asgari
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8836 3185
Email address
drasgari98429@sbmu.ac.ir
Recruitment status
recruiting
Funding source
Expected recruitment start date
2026-11-22, 1405/09/01
Expected recruitment end date
2026-12-22, 1405/10/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of Pre-induction versus Post-induction Dexmedetomidine Administration on Intraoperative Fentanyl and Isoflurane Consumption in Patients Undergoing Laparoscopic Cholecystectomy: A Double-Blind Randomized Clinical Trial
Public title
Comparison of Pre-induction versus Post-induction Dexmedetomidine Administration on Fentanyl and Isoflurane Consumption in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
ASA physical status I or II Scheduled for elective laparoscopic cholecystectomy under general anesthesia. Willingness to participate and provision of written informed consent
Exclusion criteria:
Known hypersensitivity to dexmedetomidine or study medications. Significant bradycardia, advanced atrioventricular block, or clinically significant cardiac conduction disorders. Significant cardiovascular disease or uncontrolled hypertension Severe hepatic impairment. Regular opioid use or opioid dependence. Use of dexmedetomidine or other alpha-2 agonists within the previous 7 days. Pregnancy or breastfeeding.
Age
From 18 years old to 65 years old
Gender
Both
Phase
2
Groups that have been masked
  • Participant
  • Care provider
  • Outcome assessor
Sample size
Target sample size: 78
Randomization (investigator's opinion)
Randomized
Randomization description
Eligible patients will be randomly allocated in a 1:1 ratio to the two study groups using a computer-generated random sequence. Allocation concealment will be ensured using sequentially numbered, opaque, sealed envelopes.
Blinding (investigator's opinion)
Double blinded
Blinding description
The study will be conducted in a double-blind manner. Study medications will be prepared by an independent anesthesiologist in identical syringes or infusion containers with identical labeling. Patients and outcome assessors will remain blinded to group allocation. The anesthesiologist responsible for drug preparation will not participate in outcome assessment.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Vice for Research and Technology, Shahid Beheshti University of Medical Sciences
Street address
Velenjak, Yemen Street, Shahid Shahriari Square.
City
Tehran
Province
Tehran
Postal code
1985717443
Approval date
2026-11-04, 1405/08/13
Ethics committee reference number
IR.SBMU.MSP.REC.1405.572

Health conditions studied

1

Description of health condition studied
Cholelithiasis and cholecystitis
ICD-10 code
K80.1
ICD-10 code description
Calculus of gallbladder with other cholecystitis

Primary outcomes

1

Description
Total intraoperative fentanyl consumption (µg/kg)
Timepoint
At the end of surgery and anesthesia; total fentanyl consumption will be recorded.
Method of measurement
Total intraoperative fentanyl consumption will be calculated by summing all administered doses and dividing by body weight (µg/kg).

Secondary outcomes

1

Description
total intraoperative isoflurane consumption (mL) as a secondary outcome, and compared between the two groups.
Timepoint
At the end of surgery and anesthesia; total isoflurane consumption will be recorded.
Method of measurement
Total isoflurane consumption will be recorded in milliliters (mL)

Intervention groups

1

Description
Group A : Dexmedetomidine 1 µg/kg will be administered intravenously over 10 minutes before anesthesia induction, followed by a maintenance infusion of 0.5 µg/kg/h. After induction, an equivalent-volume placebo infusion will be administered.
Category
Treatment - Drugs

2

Description
Group B : An equivalent-volume placebo will be administered over 10 minutes before anesthesia induction. Following induction, dexmedetomidine 1 µg/kg will be administered intravenously over 10 minutes, followed by a maintenance infusion of 0.5 µg/kg/h.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Loghman Hakim Hospital, Tehran, Iran.
Full name of responsible person
Masood Nashibi
Street address
Kamali St., South Kargar St
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 912 845 1648
Email
masoudnashibi@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Dr. Seyed Ali Ziaei
Street address
Velenjak Street, Shahid Shahriari Square
City
Tehran
Province
Tehran
Postal code
1985717443
Phone
+98 21 23871
Email
aliziai@sbmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Sogol Asgari
Position
Assistant Professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Kamali St., South Kargar St
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5541 9005
Email
drasgari98429@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Masood Nashibi
Position
Associate Professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Kamali St., South Kargar St
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5541 9005
Email
masoudnashibi@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Sogol Asgari
Position
Assistant Professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Kamali St., South Kargar St
City
Tehran
Province
Tehran
Postal code
1333635445
Phone
+98 21 5541 9005
Email
drasgari98429@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...